Immune-mediated myelitis associated with Hepatitis virus infections

Journal of Neuroimmunology

Volumn 239, Issue 1-2, 2011, Pages 21-27

  Stübgen, Joerg Patrick ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Hepatitis; Myelitis; Myelopathy; Post infectious; Virus

Indexed keywords

AUTOANTIBODY; CD68 ANTIGEN; CORTICOSTEROID; CRYOGLOBULIN; HEPATITIS A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN;

AUTOIMMUNITY; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID EXAMINATION; CRYOGLOBULINEMIA; DEMYELINATION; GUILLAIN BARRE SYNDROME; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS VIRUS ASSOCIATED MYELITIS; HUMAN; MACROPHAGE; MICROGLIA; MIXED INFECTION; MYELITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SPASTIC PARESIS; SPINAL CORD INJURY; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VIRUS ENTRY; VIRUS HEPATITIS;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS C, CHRONIC; HEPATITIS E; HEPATITIS, VIRAL, HUMAN; HUMANS; MYELITIS, TRANSVERSE;

EID: 80054916629     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.09.001     Document Type: Review

References (149)

1. Abramski O., Teitelbaum D. The autoimmune features of acute transverse myelopathy. Ann. Neurol. 1977, 2:36-40.
2. Acharya J.N., Pacheco V.H. Neurologic complications of Hepatitis C. Neurologist 2008, 14:151-156.
3. Adair D., Wilkinson J., Scheck A., Radkowski M., Rakela J., Laskus T. Differential display and microarray analysis show differentially expressed genes in central nervous system in HCV infected patients and laser capture microscopy points to brain microglia as cells harboring HCV. Hepatology 2004, 40:433A.
4. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J. Gastroenterol. Hepatol. 2009, 24:1484-1493.
5. Agnello V., Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum. 1997, 40:2007-2015.
6. Agnello V., DeRosa F. Extrahepatic disease manifestations of HCV infection: some current issues. J. Hepatol. 2004, 40:341-352.
7. Aiba T., Watanabe T., Koike T., Arakawa Y. C-type hepatitis in spontaneous intracerebral hemorrhage. No To Shinkei 1996, 48:1116-1119.
8. Aktipi K.M., Ravaglia S., Ceroni M., Nemni R., Debiaggi M., Bastianello S., Alfonsi E., Zardini E., Minoli L., Tavazzi E., Marchioni E. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology 2007, 68:468-469.
9. Alehan F.K., Kahveci S., Uslu Y., Yildirim T., Yilmaz B. Acute disseminated encephalomyelitis associated with hepatitis A virus infection. Ann. Trop. Paediatr. 2004, 24:141-144.
10. Alter M.J. The epidemiology of acute and chronic hepatitis C. Clin. Liver Dis. 1997, 1:559-568.
11. Alter M.J., Hadler S.C., Margolis H.S., Alexander W.J., Hu P.Y., Judson F.N., Mares A., Miller J.K., Moyer L.A. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA 1990, 263:1218-1222.
12. Alter M.J., Margolis H.S., Krawczynski K., Judson F.N., Mares A., Alexander W.J., Hu P.Y., Miller J.K., Gerber M.A., Sampliner R.E., Meeks E.L., Beach M.J. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N. Engl. J. Med. 1992, 327:1899-1905.
13. Alter M.J., Kruscon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., Kaslow R.A., Margolis H.S. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Eng. J. Med. 1999, 341:556-562.
14. Annunziata P., Marroni M., Francisci D., Stagni G. Acute transverse myelitis and hepatitis C virus. Infez. Med. 2005, 13:45-47.
15. Authier F.J., Bassez G., Payan C., Guillevin L., Pawlotsky J.M., Degos J.D., Gherardi R.K., Belec L. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 2003, 60:808-812.
16. Ayabe M., Imaizumi T., Kikuchi M., Hino H., Shoji H. Clinical and immunological findings of hepatitis B virus associated spastic paraparesis - a comparison with HAM. Rinsho Shinkeigaku 1997, 37:283-286.
17. Barnaba V. Viruses, hidden self-epitopes and autoimmunity. Immunol. Rev. 1996, 152:47-66.
18. Beeri R., Golan G., Newman D., Steiner I., Mevorach D., Brezis M. Transverse myelitis heralding hepatitis A. J. Clin. Gastroenterol. 1995, 20:262-263.
19. Berman M., Feldman S., Alter M., Zilber N., Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981, 31:966-971.
20. Bhat A., Naguwa S., Cheema G., Gershwin M.E. The epidemiology of transverse myelitis. Autoimmun. Rev. 2010, 9:A395-A399.
21. Bonetti B., Scardoni M., Monaco S., Rizzuto N., Scarpa A. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinemia. Virchows Arch. 1999, 434:533-535.
22. Bonkovsky H., Mehta S. Hepatitis C: a review and update. J. Am. Acad. Dermatol. 2001, 44:159-182.
23. Bosch V.V., Dowling P.C., Cook S.D. Hepatitis A virus immunoglobulin M antibody in acute neurological disease. Ann. Neurol. 1983, 14:685-687.
24. Breningstall G.N., Belani K.K. Acute transverse myelitis and brainstem encephalitis associated with hepatitis A infection. Paed. Neurol. 1995, 12:169-171.
25. Breuer G.S., Morali G., Finkelstein Y., Halevy J. A pregnant woman with hepatitis A and Guillain-Barré. J. Clin. Gastroenterol. 2001, 32:179-180.
26. Brickman C.M., Shoenfeld Y. The mosaic of autoimmunity. Scand. J. Clin. Lab. Invest. 2001, (Suppl. 235):3-15.
27. Bromberg K., Newhall D., Peter G. Hepatitis A and meningoencephalitis. JAMA 1982, 247:815.
28. Byrne E.A., Taylor G.F. An outbreak of jaundice with signs in the nervous system. Br. Med. J. 1945, 1:477-478.
29. Cacciatore L., Molinari V., Manzillo G., Guadignino V., Cataldo P.T., Piazza M. Letter: absence of HBsAg from cerebrospinal fluid during coma in fulminant hepatitis. Lancet 1975, 1(7904):463-464.
30. Cacoub P., Terrier B. Hepatitis B-related autoimmune manifestations. Rheum. Dis. Clin. N. Am. 2009, 35:125-137.
31. Caussin-Schwemling C., Schmitt C., Stoll-Keller F. Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro. J. Med. Virol. 2001, 65:14-22.
32. Centers for Disease Control and Prevention Protection against viral hepatitis. Recommendations of the immunization practices advisory committee (ACIP). M.M.W.R. 1990, 39:1-26.
33. Centers for Disease Control and Prevention Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the immunization practices advisory committee (ACIP). M.M.W.R. 1991, 1-19.
34. Chauhan A., Jameel S., Dilawari J.B., Chawla Y.K., Kaur U., Ganguly N.K. Hepatitis E virus transmission to a volunteer. Lancet 1993, 341:149-150.
35. Chitambar S.D., Fadnis R.S., Joshi M.S., Habbu A., Bhatia S.G. Case report: hepatitis A preceding Guillain-Barré syndrome. J. Med. Virol. 2006, 78:1011-1014.
36. Christensen P.B., Wermuth L., Hinge H.H., Bomers K. Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol. Scand. 1990, 81:431-435.
37. Clifford B.D., Donahue D., Smith L., Cable E., Luttig B., Mans M., Bonkovsky H.L. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995, 21:613-619.
38. Czaja A.J. Extrahepatic immunological features of chronic viral hepatitis. Dig. Dis. Sci. 1997, 15:125-144.
39. Dankert J., Postma A., de Vries J.A., Zijlstra J.B. Letter: HBsAg in spinal fluid from leukemic children. Lancet 1975, 1(7908):690.
40. Davis L.E., Brown J.E., Robertson B.H., Khanna B., Polish L.B. Hepatitis A post-viral encephalitis. Acta Neurol. Scand. 1993, 87:67-69.
41. Davoudi S., Soudbakhsh A., Emadikouchak H., Nikbakht G., Modabbernia A. Meningoencephalitis associated with hepatitis A infection: a case report and review of the literature. Trop. Doct. 2010, 40:176-177.
42. De Carli D.M., Pannebeker J., Pedro F.L., Haygert C.J., Hertz E., Beck Mde O. Transverse myelitis associated with HCV infection. Braz. J. Infect. Dis. 2009, 13:147-152.
43. De Seze J., Stojkovic T., Breteau G., Lucas C., Michon-Pasturel U., Gauvrit J.Y., Hachulla E., Mounier-Vehier F., Pruvo J.P., Leys D., Destée A., Hatron P.Y., Vermersch P. Acute myelopathies: clinical, laboratory and outcome profiles in 79 cases. Brain 2001, 124:1509-1521.
44. De Seze J., Lanctin C., Lebrun C., Malikova I., Papeix C., Wiertlewski S., Pelletier J., Gout O., Clerc C., Moreau C., Defer G., Edan G., Dubas F., Vermersch P. Idiopathic acute transverse myelitis: application of recent diagnostic criteria. Neurology 2005, 65:1950-1953.
45. Dienstag J.L., Szmuness W., Stevens C.E., Purcell R.H. Hepatitis A virus infection: new insights from seroepidemiologic studies. J. Infect. Dis. 1978, 137:328-340.
46. Earnest B.S., Men L.C., Sukvinder Kaur G., Alias R.B., Sunita Devi H. Chronic hepatitis C infection associated with neuromyelitis optica and antinuclear antibodies. J. Assoc. Physicians India 2010, 58:118-120.
47. Ferri C., Zignego A. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr. Opin. Rheumatol. 2000, 12:53-60.
48. Feutren G., Gerbal J.L., Allinquant B., Schuller E. Association of Guillain-Barré syndrome and B-virus hepatitis: simultaneous presence of anti-ds-DNA antibodies and HBs antigen in cerebrospinal fluid. J. Clin. Lab. Immunol. 1983, 11:161-164.
49. Ficko C., Imbert P., Mechaî F., Barruet R., Nicand E., Rapp C. Acute myelitis related to hepatitis A after travel to Senegal. Med. Trop. (Mars.) 2010, 70:7-8.
50. Filippini D., Colombo F., Jann S., Cornero R., Canesi B. Central nervous system involvement in patients with HCV-related cryoglobulinemia: literature review and case report. Reumatismo 2002, 54:150-155.
51. Francis D.P., Favero M.S., Maynard J.E. Transmission of hepatitis B virus. Semin. Liver Dis. 1981, 1:27-32.
52. Frohman E.M., Wingerchuk D.M. Transverse myelitis. N. Engl. J. Med. 2010, 263:564-572.
53. Fujinami R.S., von Herrath M.G., Christen U., Whitton J.L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin. Microbiol. Rev. 2006, 9:80-94.
54. Gerber M., Thung S.N. Molecular and cellular pathology of hepatitis B. Lab. Invest. 1985, 52:572-590.
55. Glikson M., Galun E., Orun R., Tur-Kaspa R., Shouval D. Relapsing hepatitis A. A review of 14 cases and literature review. Medicine (Baltimore) 1992, 71:14-23.
56. Grewal A.K., Lopes M.B., Berg C.L., Bennett A.K., Alves V.A., Trugman J.M. Recurrent demyelinating myelitis associated with hepatitis C viral infection. J. Neurol. Sci. 2004, 224:101-106.
57. Guignard D., Nydegger U., Lambert P.H., Miescher P.A. Physiopathology of hepatitis B virus infection. Schweiz. Med. Wochenschr. 1975, 16:1033-1040.
58. Hammond G.W., Macdougal B.K., Plummer F., Sekla L.H. Encephalitis during the prodromal stage of acute hepatitis A. Can. Med. Assoc. J. 1982, 126:269-270.
59. Hansen K.E., Arnason J., Bridges A.J. Autoantibodies and common viral illnesses. Semin. Arthritis Rheum. 1998, 27:263-271.
60. He X.Y., Fang L.J., Zhang Y.E., Sheng F.Y., Zhang X.R., Guo M.Y. In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis. Pediatr. Nephrol. 1998, 12:117-120.
61. Hickey W.F. Leukocyte traffic in the central nervous system: the participants and their roles. Semin. Immunol. 1999, 11:125-137.
62. Hino H., Ayabe M., Honda J., Shoji H., Oizumi K. Hepatitis B virus antibody positive spastic paraparesis. Clin. Neurol. 1994, 34:691-695.
63. Hoofnagle J.H. Hepatitis C: the clinical spectrum of disease. Hepatology 1997, 26:15S-20S. (Supplement).
64. Huet P.M., Layrargues G.P., Lebrun L.H., Richer G. Hepatitis B surface antigen in the cerebrospinal fluid in a case of Guillain-Barré syndrome. Can. Med. Assoc. J. 1980, 122:1157-1159.
65. Igarashi M., Tomono M., Uchida S., Yamashiro Y., Namihisa T., Tanaka S. Guillain-Barré syndrome associated with acute hepatitis A. Gastroenterol. Jpn. 1983, 18:549-552.
66. Inman R.D., Hodge M., Johnston M.E., Heathcote J. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann. Intern. Med. 1986, 105:700-703.
67. Inoue K., Yoshiba M., Yotsuyanagi R., Otsuka T., Sekiyama K., Fujita R. Chronic hepatitis A with persistent viral replication. J. Med. Virol. 1996, 50:322-324.
68. Inoue J., Ueno Y., Kogure T., Nagasaki F., Kimura O., Obara N., Kido O., Nakagome Y., Kakazu E., Matsuda Y., Fukushima K., Segawa H., Nakajima I., Itoyama Y., Takahashi M., Okamoto H., Shimosegawa T. Analysis of the full-length genome of hepatitis B virus in the serum and cerebrospinal fluid of a patient with acute hepatitis B and transverse myelitis. J. Clin. Virol. 2008, 41:301-304.
69. Jacob A., Weinshenker B.G. An approach to the diagnosis of acute transverse myelitis. Semin. Neurol. 2008, 28:105-120.
70. Jean G., Gaussorgues P., Robert D. Hepatitis B virus replication in the cerebrospinal fluid in Guillain-Barré syndrome. Presse Med. 1991, 20:428-429.
71. Jeffrey D.R., Mandler R.N., Davis L.E. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch. Neurol. 1993, 50:532-535.
72. Jouhadi Z., Ouazzani I., Abid A., El Moutawaki B., Rafai M.A., Slassi I. Devic's optic neuromyelitis and viral hepatitis type A. A paediatric case report. Rev. Neurol. (Paris) 2004, 160:1198-1202.
73. Kanda T. Chronic hepatitis C infection and peripheral neuropathy; is mixed cryoglobulinemia really important?. Intern Med. 2003, 42:377-378.
74. Kansu A., Kuloglu Z., Demiceken F., Girgin N. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha. Turk. J. Gastroenterol. 2004, 15:213-218.
75. Khemiri M., Ouederni S., Barsaoui S. A new case of acute transverse myelitis following hepatitis A virus infection. Med. Mal. Infect. 2007, 37:237-239.
76. Kim S.Y., Kim M.G., Choi W.C. Acute transverse myelitis after acute hepatitis A: findings on magnetic resonance imaging. Clin. Gastroenterol. Hepatol. 2008, 6. xxviii-e1.
77. Kincaid O., Lipton H.L. Viral myelitis: an update. Curr. Neurol. Neurosci. Rep. 2006, 6:469-474.
78. Kocabas E., Yildizdas D. A child with Guillain-Barré syndrome caused by acute hepatitis A infection. Indian Pediatr. 2004, 41:92-93.
79. Kotzin B.L., Leung J., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 1993, 54:99-166.
80. Laskus T., Radkowski M., Bednarska A., Wilkinson J., Adair D., Nowicki M., Nikolopoulou G.B., Vargas H., Rakela J. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J. Virol. 2002, 76:10064-10068.
81. Laskus T., Radkowski M., Adair D.M., Wilkinson J., Scheck A.C., Rakela J. Emerging evidence of hepatitis C virus neuroinvasion. AIDS 2005, 19(Supplement 3):S140-S144.
82. Lauer G.M., Walker G.M. Hepatitis C virus infection. N. Engl. J. Med. 2001, 345:41-52.
83. Lavi E., Suzumura A., Murray E.M., Silberberg D.H., Weiss S.R. Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection. J. Neuroimmunol. 1989, 22:107-111.
84. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 1997, 337:1733-1745.
85. Levo Y., Gorevic P.D., Kassab H.J., Zucker-Franklin D., Franklin E.C. Association between hepatitis B virus and essential mixed cryoglobulinemia. N. Engl. J. Med. 1977, 296:1501-1504.
86. Liang T.J. Hepatitis B: the virus and disease. Hepatology 2009, 49:S13-S21. (Supplement).
87. Liang T.J., Rehermann B., Seeff L.B., Hoofnagle J.H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 2000, 132:296-305.
88. Lidove O., Maisonobe T., Servan J., Thibault V., Léger J.M., Piette J.C., Cacoub P. Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia. Rev. Med. Interne 2001, 22:939-947.
89. Lipton H.L., Teasdall R.D. Acute transverse myelopathy in adults. Arch. Neurol. 1973, 28:252-257.
90. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2001, 34:1225-1241.
91. Maîga M.Y., Oberti F., Calés P. Extrahepatic manifestations of hepatitis A virus infection. Gastroenterol. Clin. Biol. 1996, 20:346-352.
92. Mandal K., Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr. 2006, 43:365-366.
93. Mason A. Role of viral replication in extrahepatic syndromes related to hepatitis B virus infection. Minerva Gastroenterol. Dietol. 2006, 52:53-66.
94. Mason A., Theal J., Bain V., Adams E., Perrillo R. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease. Am. J. Gastroenterol. 2005, 100:972-976.
95. Matsui M., Kakigi R., Watanabe S., Kuroda Y. Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier. J. Neurol. Sci. 1996, 139:235-237.
96. Matsushima K., Niwa K., Fujita H., Yamamoto M., Shinohara Y. Acute hepatitis A (HA) presenting findings of meningoencephalitis. Rinsho Shinkeigaku 1992, 32:441-443.
97. Maya R., Gershwin M.E., Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clinic. Rev. Allerg. Immunol. 2008, 34:85-102.
98. Mayo M.J. Extrahepatic manifestations of hepatitis C infection. Am. J. Med. Sci. 2003, 325:135-148.
99. McCoy L., Tsunoda I., Fujinami R.S. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 2006, 39:9-19.
100. McDonald G.S., Courtney M.G., Shattock A.G., Weir D.G. Prolonged IgM antibodies and histopathological evidence off chronicity in hepatitis A. Liver 1989, 9:223-238.
101. McMahon B.J., Alward W.L., Hall D.B., Heyward W.L., Bender T.R., Francis D.P., Maynard J.E. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis. 1985, 151:599-603.
102. Miller R.H., Robinson W.S. Common evolutionary origin of hepatitis B virus and retroviruses. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:2531-2535.
103. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch K.L., Neville Y., Katz-Levy A., Carrizosa A., Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997, 3:1133-1136.
104. Mouelhi L., Mekki H., Houissa F., Debbeche R., Ben Rejeb M., Bouzaidi S., Trabelsi S., Salem M., Najjar T. Transverse myelitis associated with chronic viral hepatitis C. Tunis Med. 2010, 88:116-118.
105. Nahill S.R., Welsh R.M. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 1993, 177:710-715.
106. Nemni R., Sanvito L., Quattrini A., Santuccio G., Camerlingo M., Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinemia. J. Neurol. Neurosurg. Psychiatry 2003, 74:1267-1271.
107. Nishimura M., Shigemoto R., Matsubayashi K., Mimori Y., Kameyama M. Meningoencephalitis during the pre-icteric phase of hepatitis A - a case report. Rinsho Shinkeigaku 1987, 27:1441-1444.
108. Nishioka K. Epidemiological studies on hepatitis C virus infection: detection, prevalence, exposure and prevention. Intervirology 1994, 37:58-67.
109. Nolte C.H., Endres A.S., Meisel H. Sensory ataxia in myelopathy with chronic hepatitis C virus infection. Neurology 2002, 59:958.
110. Nothdurft H.D. Hepatitis A vaccines. Expert Rev. Vaccines 2008, 7:535-545.
111. Olson J.K., Croxford J.L., Miller S.D. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol. 2001, 14:227-250.
112. Pacheco V.H., Acharya J.N. Recurrent myelopathy and hepatitis C infection. Ann. Neurol. 2006, 60(Supplement 3):S45.
113. Parajuå J.L., Riera M., Garcîa M.J. Hepatitis A encephalitis. Med. Clin. (Barc.) 1991, 97:279.
114. Pelletier G., Elghozi D., Trepo C., Laverdant C., Benhamou J.P. Mononeuritis in acute viral hepatitis. Digestion 1985, 32:53-56.
115. Penner E., Maida E., Mamoli B., Gangl A. Serum and cerebrospinal fluid immune complexes containing hepatitis B surface antigen in Guillain-Barré syndrome. Gastroenterology 1982, 82:576-580.
116. Petty G.W., Duffy J., Houston J. Cerebral ischemia in patients with hepatitis C virus infection and cryoglobulinemia. Mayo Clin. Proc. 1996, 71:671-678.
117. Pines E., Pines A. Aseptic meningitis: a rare prodromal manifestation of infectious hepatitis. Harefuah 1982, 102:110-111.
118. Pischke S., Potthoff A., Hauroder B., Schlué J., Manns M.P., Cornberg M., Wedemeyer H. Hepatitis E virus infection: a paradigm shift?. Dtsch. Med. Wochenschr. 2010, 135:1129-1133.
119. Porst H., Hentschel R., Sauermann W., Lehmann H.U., Lohmann J., Schentke K.U. Guillain-Barré polyradiculitis in acute viral hepatitis type B: case report. Dtsch. Z. Verdau. Stoffwechselkr. 1983, 43:146-149.
120. Probst T., Probst A., Nachbauer K., Graziadei I., Willeit H., Margreiter R., Vogel W. Papillitis and vasculitis of the arteria spinalis anterior as complication of hepatitis C reinfection after liver transplantation. Transpl. Int. 1997, 10:234-237.
121. Radkowski M., Wilkinson J., Nowicki M., Adair D., Vargas H., Ingui C., Rakela J., Laskus T. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J. Virol. 2002, 76:600-608.
122. Ramos-Casals M., Font J. Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr. Opin. Rheumatol. 2005, 17:447-455.
123. Rao U.B., Suri M.L., Gupta S. Infectious hepatitis with myelitis and neuritis. J. Indian Med. Assoc. 1968, 51:460-463.
124. Ropper A.H., Poskanzer D.C. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Neurology 1978, 4:51-59.
125. Sansonno D., Iacobelli A.R., Cornacchiulo V., Iodice G., Damacco F. Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotope in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients. Clin. Exp. Immunol. 1996, 103:414-421.
126. Schiff E.R. Atypical clinical manifestations of hepatitis A. Vaccine 1992, 10:S18-S20.
127. Schiliro G., Russo A., Marino S., Musumeci S. HBsAg in spinal fluid in leukemia. Lancet 1975, 2(7939):816-817.
128. Seeger C., Ganem D., Varmus H.E. Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 1986, 232:477-484.
129. Selves J., Kamar N., Mansuy J.M., Péron J.M. Hepatitis E virus: a new entity. Ann. Pathol. 2010, 30:432-438.
130. Séne D., Limal N., Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. Metab. Brain Dis. 2004, 19:357-381.
131. Simonetti R.G., Camma C., Fiorello F., Cottone M., Rapicetta M., Marino L., Fiorentino G., Craxi A., Ciccaglione A., Giuseppetti R., Stroffolini T., Pagliaro L. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case control study. Ann. Intern. Med. 1992, 116:97-102.
132. Sobukawa E., Sakimura K., Hoshino S., Hoshino M., Miyoshi K. Hepatic myelopathy: an unusual neurological complication of advanced liver disease. Int. Med. 1994, 33:718-722.
133. Spiegel R.J., Tabor E., Pizzo P.A., Gerety R.J. Hepatitis B surface antigen in spinal fluid. Med. Pediatr. Oncol. 1980, 8:115-121.
134. Tabor E. Guillain-Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B. J. Med. Virol. 1987, 21:207-216.
135. Takahashi-Fujigasaki J., Takagi S., Sakamoto T., Inoue K. Spinal cord biopsy findings of anti-aquaporin-4 antibody-negative recurrent longitudinal myelitis in a patient with sicca and hepatitis C viral infection. Neuropathology 2009, 29:472-479.
136. Teshale E.H., Hu D.J., Holmberg S.D. The two faces of hepatitis E virus. Clin. Infect. Dis. 2010, 51:328-334.
137. Thapa R., Biswas B., Mallick D., Mukherjee S. Pharyngeal-cervical-brachial variant of pediatric Guillain-Barré syndrome with antecedent acute hepatitis A infection. J. Child Neurol. 2009, 24:865-867.
138. Tiollais P., Pourcel C., Dejean A. The hepatitis B virus. Nature 1985, 317:489-495.
139. Transverse Myelitis Consortium Working Group Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59:499-505.
140. Trepo C., Bolot J.F., Robert D., Sepetjian M., Prince A.M. Letter: absence of HBsAg and anti-HBs in spinal fluid. Lancet 1974, 2(7895):1514.
141. Tsukada N., Koh C.S., Inoue A., Yanagisawa N. Demyelinating neuropathy associated with hepatitis B virus infection. Detection of immune complexes composed of hepatitis B virus surface antigen. J. Neurol. Sci. 1987, 77:203-216.
142. Tyler K.L., Gross R.A., Cascino G.D. Unusual viral causes of transverse myelitis: hepatitis A virus and cytomegalovirus. Neurology 1986, 36:855-858.
143. Valentini G., Mantelli A., Persico M., Tuccillo C., Del Veccho Blanco G., Morisco F., Improta R.D., Migliaresi S., Gualdieri L., Caporaso N. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions. Clin. Exp. Rheumatol. 1999, 17:75-79.
144. Vishwanathan R. Infectious hepatitis in Delhi (1955-1956): a critical study: epidemiology. Indian J. Med. Res. 1957, 45(Supplement 1):1-29.
145. Wasley A., Fiore A., Bell B.P. Hepatitis A in era of vaccination. Epidemiol. Rev. 2006, 28:101-111.
146. Wilson R.A. Extrahepatic manifestations of chronic viral hepatitis. Am. J. Gastroenterol. 1997, 92:3-17.
147. Wucherpfennig K.W. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest. 2001, 108:1097-1104.
148. Yoffe B., Burns D.K., Bhate H.S., Combes B. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. Hepatology 1990, 12:187-192.
149. Zandman-Goddard G., Levy Y., Weiss P., Shoenfeld Y., Langevitz P. Transverse myelitis associated with chronic hepatitis C. Clin. Exp. Rheumatol. 2003, 21:111-113.